Article
Different involvement of the megakaryocytic lineage by the JAK2 V617F mutation in Polycythemia vera, essential thrombocythemia and chronic idiopathic myelofibrosis.
Annals of hematology - 1 Apr 2007
Hussein Kais, Brakensiek Kai, Buesche Guntram, Buhr Thomas, Wiese Birgitt, Kreipe Hans, Bock Oliver
Abstract excerpt
Atypical megakaryocytes provide the histomorphological hallmark of all Philadelphia-chromosome negative chronic myeloproliferative disorder (Ph(-) CMPD) subtypes and have not been studied so far for the JAK2(V617F) mutation. The mutant gene dosage was determined in isolated megakaryocytes from 68 cases of JAK2(+)/Ph(-) CMPD by a pyrosequencing assay. Megakaryocytes from essential thrombocythemia (ET) showed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
